{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:52:40Z","timestamp":1754153560159,"version":"3.41.2"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtct.2025.06.023","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:12:57Z","timestamp":1751379177000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herombopag Versus rhTPO in Stem Cell Transplantation: A Comparative Study of Efficacy, Safety, and Cost-Effectiveness"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-6407","authenticated-orcid":false,"given":"Fenglian","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-9582","authenticated-orcid":false,"given":"Zhiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-4006","authenticated-orcid":false,"given":"Yun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9283-0555","authenticated-orcid":false,"given":"Hanqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-9965","authenticated-orcid":false,"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5522-3193","authenticated-orcid":false,"given":"Chun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.06.023_bib0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hemonc.2019.08.003","article-title":"Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients","volume":"13","author":"Lutfi","year":"2020","journal-title":"Hematol\/Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2025.06.023_bib0002","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1182\/blood-2023-191091","article-title":"Recombinant Human Thrombopoietin Combined with Thrombopoietin Receptor Agonists Can Facilitate the Recovery of Platelet after Allogeneic HSCT","volume":"142","author":"Cheng","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.06.023_bib0003","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00277-024-05711-1","article-title":"Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation","volume":"103","author":"Zhou","year":"2024","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.jtct.2025.06.023_bib0004","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00277-024-05826-5","article-title":"Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial","volume":"103","author":"Mei","year":"2024","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.jtct.2025.06.023_bib0005","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T07:57:23Z","timestamp":1753257443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":5,"alternative-id":["S2666636725012667"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herombopag Versus rhTPO in Stem Cell Transplantation: A Comparative Study of Efficacy, Safety, and Cost-Effectiveness","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}